Integrated transcriptome and methylome profiling identified possible key regulators in the tumor-reactive subtype, including exhaustion-related TFs such as NR4A1, BATF, and EGR2. Novel TFs RUNX1 and VDR identified here need further validation and may serve as potential therapeutic targets. Here, EGR2 is linked to neoplasm.